CBD Use and Liver Injury: Practical Considerations for Primary Care - Frankly Speaking Ep 339 - podcast episode cover

CBD Use and Liver Injury: Practical Considerations for Primary Care - Frankly Speaking Ep 339

Jul 31, 20239 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-339

Overview: In this episode, we dive into a recent systematic review and meta-analysis confirming the association between cannabidiol (CBD) use and hepatotoxicity. Gain a deeper understanding of clinical applications and the delicate balance of risks and benefits when discussing CBD use with your patients.

Episode resource links:

  • Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023 Mar 13. doi: 10.1111/joim.13627. Epub ahead of print. PMID: 36912195.
  • https://store.samhsa.gov/sites/default/files/pep22-06-04-003.pdf

Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato

For the best experience, listen in Metacast app for iOS or Android